Clinical Trial

Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2

Study acronym: TIMERS-2
Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates the safety and efficacy of early versus delayed initiation of direct oral anticoagulants (DOACs) in patients with acute ischemic stroke related to atrial fibrillation who develop hemorrhagic transformation after endovascular treatment.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-08-17; most recent amendment 2026-02-04.
Status change: Not Yet Recruiting → Recruiting 2025-08-23
Trial Details
NCT Number NCT07139314
Lead Sponsor Capital Medical University
Conditions Ischemic Stroke, Atrial Fibrillation
Enrollment 240 participants
Start Date 2025-09-24
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-05